Towards Healthcare
Diagnostic Testing Market to Reach USD 274.53 Bn by 2034

Diagnostic Testing Market 2025 Driven by Early Diagnosis

Market insights predict, the diagnostic testing industry is expected to grow from USD 203.3 billion in 2024 to USD 274.53 billion by 2034, driven by a CAGR of 3.04%. The rising prevalence of chronic and infectious diseases is estimated to drive the growth of the market. North America led the global market owing to its advanced healthcare infrastructure in the region.

Content

  • Last Updated: 22 September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The diagnostic testing market stands at USD 209.48 billion in 2025 and is expected to reach USD 274.53 billion by 2034, growing at a CAGR of 3.04% from 2024 to 2034.

North America is leading the diagnostic testing market share 40% due to the rising demand for personalized medicines, rising government initiatives, and the presence of key players.

Some key players include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Danaher Corporation (Cepheid, Beckman Coulter), and Thermo Fisher Scientific, among others.

Key trends include telehealth and remote monitoring, increasing investments, and the adoption of inorganic growth strategies.

Association for Diagnostics & Laboratory Medicine (ADLM), Personalized Medicine Coalition, American Clinical Laboratory Association, Government of Canada, BIVDA - The British In Vitro Diagnostic Association, Food and Drug Administration, Association for Molecular Pathology, clinicaltrials.gov, and GOV.UK, among others.
Any Questions